Trials / Sponsors / Tahir Latif
Tahir Latif
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymp Non Hodgkin Lymphoma | Phase 2 | 2018-10-29 |